Insider · CIK 0001201096
Kevin Charles Gorman
Files at NBIX (NEUROCRINE BIOSCIENCES INC), XNCR (Xencor Inc). First filing Jan 29, 2025, latest Aug 11, 2025.
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
NBIX: NEUROCRINE BIOSCIENCES INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
XNCR: Xencor Inc
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 10Weak | NEUROCRINE BIOSCIENCES INC | $13M 106,322 shares | -17% | +43% from low-18% from high | |
| 20Weak | Xencor Inc | $29k 3,173 shares | -14% | +20% from low-66% from high | |
| 20Weak | NEUROCRINE BIOSCIENCES INC | $1.2M 9,613 shares | -2% | +40% from low-20% from high | |
| 16Weak | NEUROCRINE BIOSCIENCES INC | $682k 5,844 shares | -1% | - | |
| 8Weak | NEUROCRINE BIOSCIENCES INC | $269k 2,274 shares | -0% | - | |
| 11Weak | NEUROCRINE BIOSCIENCES INC | $414k 2,707 shares | -1% | - | |
| 25Weak | NEUROCRINE BIOSCIENCES INC | $22M 146,105 shares | -22% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | AGrant or award Common Stock | +14,343 | $0.00 | $0 | 525,636 | 27 d ago |
| Sep 11, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | FTax withholding Common Stock | -7,839 | $156.22 | $1.2M | 517,797 | 27 d ago |
| Aug 7, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Common Stock10b5-1 | +106,322 | $35.99 | $3.8M | 620,918 | Aug 11, 2025 |
| Aug 7, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | SOpen-market sale Common Stock10b5-1 | -106,322 | $126.41 | $13M | 514,596 | Aug 11, 2025 |
| Aug 7, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Non-Qualified Stock Optionderivative10b5-1 | -106,322 | $0.00 | $0 | 0 | Aug 11, 2025 |
| Jun 12, 2025 | XNCR Xencor Inc | AGrant or award Common Stock10b5-1 | +13,686 | $0.00 | $0 | 22,078 | Jun 16, 2025 |
| Jun 16, 2025 | XNCR Xencor Inc | SOpen-market sale Common Stock10b5-1 | -3,173 | $9.22 | $29k | 18,905 | Jun 16, 2025 |
| Jun 12, 2025 | XNCR Xencor Inc | AGrant or award Stock Option (Right to Buy)derivative10b5-1 | +27,372 | $0.00 | $0 | 27,372 | Jun 16, 2025 |
| May 27, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | SOpen-market sale Common Stock10b5-1 | -9,613 | $120.38 | $1.2M | 514,596 | May 29, 2025 |
| May 21, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | AGrant or award Non-Qualified Stock Optionderivative | +6,610 | $0.00 | $0 | 6,610 | May 22, 2025 |
| Feb 13, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Common Stock10b5-1 | +5,376 | $0.00 | $0 | 524,450 | Feb 14, 2025 |
| Feb 13, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | SOpen-market sale Common Stock10b5-1 | -2,832 | $116.69 | $330k | 521,618 | Feb 14, 2025 |
| Feb 13, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Common Stock10b5-1 | +5,603 | $0.00 | $0 | 527,221 | Feb 14, 2025 |
| Feb 13, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | SOpen-market sale Common Stock10b5-1 | -3,012 | $116.68 | $351k | 524,209 | Feb 14, 2025 |
| Feb 13, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Restricted Stock Unitderivative10b5-1 | -5,376 | $0.00 | $0 | 10,754 | Feb 14, 2025 |
| Feb 13, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Restricted Stock Unitderivative10b5-1 | -5,603 | $0.00 | $0 | 16,812 | Feb 14, 2025 |
| Feb 8, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Common Stock10b5-1 | +4,318 | $0.00 | $0 | 521,348 | Feb 12, 2025 |
| Feb 10, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | SOpen-market sale Common Stock10b5-1 | -2,274 | $118.37 | $269k | 519,074 | Feb 12, 2025 |
| Feb 8, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Restricted Stock Unitderivative10b5-1 | -4,318 | $0.00 | $0 | 0 | Feb 12, 2025 |
| Jan 31, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Common Stock10b5-1 | +5,141 | $0.00 | $0 | 519,737 | Feb 4, 2025 |
| Jan 31, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | SOpen-market sale Common Stock10b5-1 | -2,707 | $152.92 | $414k | 517,030 | Feb 4, 2025 |
| Jan 31, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Restricted Stock Unitderivative10b5-1 | -5,141 | $0.00 | $0 | 5,142 | Feb 4, 2025 |
| Jan 27, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Common Stock10b5-1 | +146,105 | $32.99 | $4.8M | 660,701 | Jan 29, 2025 |
| Jan 27, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | SOpen-market sale Common Stock10b5-1 | -146,105 | $149.46 | $22M | 514,596 | Jan 29, 2025 |
| Jan 27, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Non-Qualified Stock Optionderivative10b5-1 | -146,105 | $0.00 | $0 | 0 | Jan 29, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.